Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2014-03-25 | cabozantinib | Exelixis (USA) | metastasized medullary thyroid cancer | Granting of a Market Authorisation in the EU |
2015-10-27 | lorcaserin hydrochloride | Arena Pharmaceuticals (USA - CA) Eisai (Japan) | chronic weight management | Granting of a patent |
2013-01-03 | peginesatide | Affymax (USA) Takeda Pharmaceutical (Japan) | anemia in adult patients on dialysis |
|
2013-01-03 | lucinactant (synthetic peptide) | Discovery Laboratories (USA) | prevention of respiratory distress syndrome (RDS) | |
2016-10-28 | recombinant Factor IX Fc fusion protein (rFIXFc) - eftrenonacog alfa | BiogenIdec (USA - MA) Swedish Orphan Biovitrum (Sobi) (Sweden) | hemophilia B |
Reimbursement |
2016-08-08 | aripiprazole lauroxil | Alkermes (Ireland) | schizophrenia |
Granting of a patent |
2012-02-23 | ulipristal acetate | Preglem (Switzerland) member of the Richter Group (Hungary) | pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age |
Granting of a Market Authorisation in the EU |
2017-02-28 | afatinib | Boehringer Ingelheim (Germany) |
|
Granting of a Market Authorisation in China |
2013-01-16 | EGFR test - PCR companion diagnostic | Qiagen (The Netherlands) | locally advanced or metastatic non-small cell lung cancer (NSCLC) with an epidermal growth factor receptor (EGFR) mutation |
Granting of a Market Authorisation in the US |
2013-01-16 | albiglutide | GSK (UK) | type 2 diabetes |
Granting of a Market Authorisation in the US |
2013-01-17 | Cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys | Apeptico Forschung und Entwicklung GmbH (Austria) | high altitude pulmonary oedema |
|
2013-01-17 | progesterone | BHR Pharma Belgium (Belgium) | moderate and severe traumatic brain injury | |
2013-01-17 | treprostinil sodium | SciPharm Sarl | chronic thromboembolic pulmonary hypertension | |
2013-01-17 | humanised monoclonal antibody against myostatin | Pfizer (USA - NY) | Duchenne muscular dystrophy |
Granting of the orphan status in the EU |
2013-01-17 | humanised IgG1 kappa antibody against serum amyloid A and AL amyloid | Onclave Therapeutics (Elan\'s subsidiary - Ireland) | amyloid light-chain amyloidosis | |
2013-01-17 | L-asparaginase encapsulated in erythrocytes | ERYtech Pharma (France) | acute myeloid leukaemia | Granting of the orphan status in the US |
2013-01-17 | recombinant adeno-associated viral vector containing the human CNGB3 gene | TMC Pharma (UK) | achromatopsia caused by mutations in the CNGB3 gene |
Granting of a patent |
2013-01-17 | terguride | High Tech Participations GmbH (Germany) | systemic sclerosis | |
2017-09-28 | ocriplasmin | Thrombogenics (Belgium) - Alcon, a division of Novartis (Switzerland) |
|
Product launch |
2013-01-22 | ADX71441 | Addex Therapeutics (Switzerland) |
© 2024 Biopharmanalyses - Powered by Samacom+